Sanofi delivered close to double digit Q4 2020 business EPS growth at CER
Fourth quarter and full-year 2020 results were reviewed by management during a live audio webcast with the financial community.
Fourth quarter and full-year 2020 results were followed by a virtual Capital Markets Day (CMD21).
I am incredibly proud of the measurable progress we made in 2020 even in the face of a global pandemic. We'll stay the course in 2021, focused on bringing breakthrough medicines and vaccines to people around the world.
Chief Executive Officer